The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1499
ISSUE1499
July 18, 2016
Onzetra Xsail - Sumatriptan Nasal Powder
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Onzetra Xsail - Sumatriptan Nasal Powder
July 18, 2016 (Issue: 1499)
The FDA has approved Onzetra Xsail (Avanir), a nasal
powder formulation of sumatriptan, for acute treatment
of migraine in adults. Nasal spray formulations of
sumatriptan (Imitrex) and zolmitriptan (Zomig) have
been available for many...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.